drugset / Trial / NCT00279747
A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)
RandomizedParallel-groupDouble-blindTreatment
Summary
A one year double-blind trial to investigate the efficacy and safety of meloxicam oral suspension 0.25 mg/kg and 0.125 mg/kg administered once daily in comparison to naproxen oral suspension 5 mg/kg administered twice daily in children with Juvenile Rheumatoid Arthritis.
Timeline
- Start
- 2000-09
- Primary completion
- 2003-01
- Completion
- 2003-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meloxicam | Small molecule | 0.125 mg/kg | Oral |
| Subject | Meloxicam | Small molecule | 0.25 mg/kg | Oral |
| Subject | Naproxen | Small molecule | 10 mg/kg | Oral |